Su-5402 A New Ray of Light in the Research for an Anti Cancer Drug
With the discovery of the AC220, it became quite possible curing acute myeloid leukemia. This disease affects a person generally at his adult age and the symptoms get on growing worse along with the increase of the age.

With the discovery of the AC220, it became quite possible curing acute myeloid leukemia. This disease affects a person generally at his adult age and the symptoms get on growing worse along with the increase of the age. The work which AC22O actually does is, it stops the abnormal growth of the white bloods so that the growth of the red blood cells does not inhibited and also that the white blood cells can grow at a normal rate on its own.
All this much needed information was gathered from http://www.synkinase.com which is an extremely powerful resource of information as well as education in the field of medical research and discovery of new drugs for curing diseases. This site gives much needed information about the remedies of different forms of cancer. FGFR inhibitor and PDGFR inhibitor is an important drug in the field of medical research which have been brought to light by this site.
http://www.synkinase.com/
###
Tag Words:
ac220, tasocitinib
Categories: Health
Press Release Contact
Synkinase, PO Box 7890
San Diego CA, 92167, USA
1-877-854-6273
Synkinase, PO Box 7890
San Diego CA, 92167, USA
1-877-854-6273